Tidepool
See the following -
Healthcare Lessons from the Data Sages at Strata
Most healthcare clinicians don't often think about donating or sharing data. Yet, after hearing Stephen Friend of Sage Bionetworks talk about involving citizens and patients in the field of genetic research at StrataRx 2012, I was curious to learn more...With this in mind, I arrived at this February's Strata conference wondering what I could extrapolate from other more sophisticated data users to healthcare.
- Login to post comments
How Radical Transparency Is Transforming Open Source Healthcare Software
At Tidepool, where I work as a Community and Clinic Success Manager, the company's mission is to make diabetes software more accessible, meaningful, and actionable. Operating in the open is how we achieve that. Tidepool's diabetes management software is an open source platform free for both clinicians and people impacted by diabetes. And, because the company is a nonprofit, it also operates according to the transparency rules that govern 501(c)(3) organizations.
- Login to post comments
JDRF And Tidepool Partner To Bring Data To An Open Source Platform For People With Type 1 Diabetes
JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, and Tidepool ™, a Silicon Valley-based non-profit organization committed to reducing the burden of T1D, announced a partnership supported by JDRF funding for data access technology for people with T1D who use insulin pumps and continuous glucose monitors (CGMs) through a device agnostic cloud platform...
- Login to post comments
Top 10 eClinical Trends
The drug development industry is facing a revolution in the way clinical trials are being planned and conducted. It’s an industry that experiences rapid changes in technology adoption and business models, from new ways of capturing clinical data to new outsourcing strategies. This paper focuses on ten essential eClinical trends in order to help you understand which direction the biotech industry is prone to take in the next few years. As both the means, and the ultimate motivation of clinical development, patients are the most fundamental assets during the clinical trial process. We have summed up five trends that are destined to give them a more important role in the conduct of clinical studies: Boosting Patient Engagement, Integrated ePRO (electronic Patient Reported Outcomes) Systems, Mobile Clinical Studies, Personalized medicine, and Risk-based monitoring. Read More »
- Login to post comments